Carmel Moore

Carmel Moore

Auto-generated profile, based on publicly available information

Carmel Moore

Anglia Ruskin University, Chelmsford, UK

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in The Lancet Haematology
Verified
Journal Article
Open access
SKStephen Kaptoge
Stephen Kaptoge
EAEmanuele Di Angelantonio
Emanuele Di Angelantonio
CMCarmel Moore
Carmel Moore
MWMatthew Walker
Matthew Walker
JAJane Armitage
Jane Armitage
JMJonathan Mant
Jonathan Mant
The INTERVAL trial showed that, over a 2-year period, inter-donation intervals for whole blood donation can be safely reduced to meet blood shortages. We extended the INTERVAL trial for a further 2 years to evaluate the longer-term risks and benefits of varying inter-donation intervals, and to compare routine versus more intensive reminders to help donors keep appointments. The INTERVAL trial was a parallel group, pragmatic, randomised trial that recruited blood donors aged 18 years or older from 25 static donor centres of NHS Blood and Transplant across England, UK. Here we report on the prespecified analyses after 4 years of follow-up. Participants were whole blood donors who agreed to continue trial participation on their originally allocated inter-donation intervals (men: 12, 10, and 8 weeks; women: 16, 14, and 12 weeks). They were further block-randomised (1:1) to routine versus more intensive reminders using computer-generated random sequences. The prespecified primary outcome was units of blood collected per year analysed in the intention-to-treat population. Secondary outcomes related to safety were quality of life, self-reported symptoms potentially related to donation, haemoglobin and ferritin concentrations, and deferrals because of low haemoglobin and other factors. This trial is registered with ISRCTN, number ISRCTN24760606, and has completed. Between Oct 19, 2014, and May 3, 2016, 20 757 of the 38 035 invited blood donors (10 843 [58%] men, 9914 [51%] women) participated in the extension study. 10 378 (50%) were randomly assigned to routine reminders and 10 379 (50%) were randomly assigned to more intensive reminders. Median follow-up was 1·1 years (IQR 0·7-1·3). Compared with routine reminders, more intensive reminders increased blood collection by a mean of 0·11 units per year (95% CI 0·04-0·17; p=0·0003) in men and 0·06 units per year (0·01-0·11; p=0·0094) in women. During the extension study, each week shorter inter-donation interval increased blood collection by a mean of 0·23 units per year (0·21-0·25) in men and 0·14 units per year (0·12-0·15) in women (both p<0·0001). More frequent donation resulted in more deferrals for low haemoglobin (odds ratio per week shorter inter-donation interval 1·19 [95% CI 1·15-1·22] in men and 1·10 [1·06-1·14] in women), and lower mean haemoglobin (difference per week shorter inter-donation interval -0·84 g/L [95% CI -0·99 to -0·70] in men and -0·45 g/L [-0·59 to -0·31] in women) and ferritin concentrations (percentage difference per week shorter inter-donation interval -6·5% [95% CI -7·6 to -5·5] in men and -5·3% [-6·5 to -4·2] in women; all p0.0001 for tests of linear trend by inter-donation intervals) other than a higher reported frequency of doctor-diagnosed low iron concentrations and prescription of iron supplements in men (p<0·0001). During a period of up to 4 years, shorter inter-donation intervals and more intensive reminders resulted in more blood being collected without a detectable effect on donors' mental and physical wellbeing. However, donors had decreased haemoglobin concentrations and more self-reported symptoms compared with the initial 2 years of the trial. Our findings suggest that blood collection services could safely use shorter donation intervals and more intensive reminders to meet shortages, for donors who maintain adequate haemoglobin concentrations and iron stores. NHS Blood and Transplant, UK National Institute for Health Research, UK Medical Research Council, and British Heart Foundation.

1 December 2018 in Health Services and Delivery Research
Verified
Journal Article
Closed access
RGRichard Grieve
Richard Grieve
SWSarah Willis
Sarah Willis
KCKaat De Corte
Kaat De Corte
MSM Zia Sadique
M Zia Sadique
NHNeil Hawkins
Neil Hawkins
MJMiflin G & Cairns Ja
Miflin G & Cairns Ja
Background: Evidence is required on the cost-effectiveness of alternative changes to the blood collection service.Objectives: (1) To estimate the cost-effectiveness of alternative minimum interdonation intervals between whole-blood donations. (2) To investigate donors’ frequency of whole-blood donation according to alternative changes to the blood collection service. (3) To estimate the cost-effectiveness of alternative strategies for maintaining the supply of whole blood.Methods: We undertook a within-trial cost-effectiveness analysis (CEA) of the INTERVAL trial, stated preference (SP) surveys to elicit donor preferences and a CEA of different strategies for blood collection. The strategies considered were reduced minimum intervals between whole-blood donations, introduction of a donor health report and changes to appointment availability and opening times at blood collection venues. The within-trial CEA included 44,863 donors, with men randomly assigned to 12- versus 10- versus 8-week interdonation intervals, and women to 16- versus 14- versus 12-week interdonation intervals. We undertook a SP survey of non-INTERVAL donors (100,000 invitees). We asked donors to state the frequency with which they would be willing to donate blood, according to the service attribute and level. The CEA compared changes to the blood service with current practice by combining the survey estimates with information from the NHS Blood and Transpant database (PULSE) and cost data. The target population was existing whole-blood donors in England, of whom approximately 85% currently donate whole blood at mobile (temporary) blood collection venues, with the remainder donating at static (permanent) blood collection centres. We reported the effects of the alternative strategies on the number of whole-blood donations, costs and cost-effectiveness.Results: The reduced donation interval strategies had higher deferral rates caused by low haemoglobin (Hb), but increased frequency of successful donation. For men in the 8- versus 12-week arm of the INTERVAL trial [Di Angelantonio E, Thompson SG, Kaptoge S, Moore C, Walker M, Armitage J,et al.Efficiency and safety of varying the frequency of whole blood donation (INTERVAL): a randomised trial of 45 000 donors.Lancet2017;390:2360–71], the Hb-related deferral rate was 5.7% per session versus 2.6% per session, but the average number of donations over 2 years increased by 1.71 (95% confidence interval 1.60 to 1.80). A total of 25,187 (25%) donors responded to the SP survey. For static donor centres, extending appointment availability to weekday evenings or weekends, or reduced intervals between blood donations, increased stated donation frequency by, on average, 0.5 donations per year. The CEA found that reducing the minimum interval, extending opening times to weekday evenings and extending opening times to weekends in all static donor centres would provide additional whole blood at a cost per additional unit of £10, £23 and £29, respectively, with similar results for donors with high-demand blood types.Limitations: The study did not consider the long-term rates at which donors will leave the donation register, for example following higher rates of Hb-related deferral.Conclusions: Extending opening hours for blood donation to weekday evenings or weekends for all static donor centres are cost-effective ways of increasing the supply of high-demand blood types.Future work: To monitor the effects of new strategies on long-term donation frequency.Funding: The National Institute for Health Research Health Services and Delivery Research programme.

1 May 2008 in Proceedings of the Nutrition Society
Verified
Journal Article
Open access
PDF file
SJSusan Jebb
Susan Jebb
LBLes Bluck
Les Bluck
MCMark Chatfield
Mark Chatfield
GFGary Frost
Gary Frost
RGRachel Gitau
Rachel Gitau
TSTom Sanders
Tom Sanders


22 September 2026 in Autism
Verified
Journal Article
Open access
CHClaire Howlin
Claire Howlin
AKAnna Kovalova
Anna Kovalova
AJArtur Jaschke
Artur Jaschke
DGDavid M Greenberg
David M Greenberg
BMBeth Mason
Beth Mason
SBSimon Baron-Cohen
Simon Baron-Cohen
Reliable measurement of social communication change remains a major challenge in autism research. The Brief Observation of Social Communication Change (BOSCC) was developed to detect subtle changes in communication. This rapid review synthesised current evidence on the BOSCC’s responsiveness, validity, and suitability as a clinical trial endpoint. Systematic searches of PubMed, PsycINFO, CINAHL, and Web of Science identified 19 eligible studies ( n = 789). Within-group meta-analyses estimated pre–post standardised mean change (Hedges’ g ) for BOSCC and ADOS (Autism Diagnostic Observation Schedule) outcomes, using random-effect (RE) models. The BOSCC total score for intervention arms showed a moderate, significant change ( g = −0.32, 95% confidence interval [CI] = [−0.42, −0.22]), with a smaller, non-significant change in control arms ( g = −0.15). The Social Communication subscale yielded consistent effects on the intervention arm ( g = −0.34, 95% CI = [−0.49, −0.19]), indicating sensitivity to improvements in reciprocal interaction. The restricted and repetitive behaviour (RRB) subscale also showed a moderate significant effect on the intervention arm but with wide confidence intervals indicating a large degree of heterogeneity in this result ( g = −0.40, 95% CI = [−0.74, −0.06]). ADOS scores showed a similar pattern of results for the intervention arms, based on a sub-analysis of four studies that included both BOSCC and ADOS scores. Findings indicate that the BOSCC captures clinically meaningful behavioural change across diverse contexts. Variability in RRB outcomes may arise because they are not routinely targeted by supports for social communication, in line with neuro-affirmative approaches. Lay Autism research often aims to understand how different supports can help autistic children develop skills that are important to them and their families, such as social communication. However, changes in social communication are very difficult to measure. The Brief Observation of Social Communication Change (BOSCC) was developed to help address this. It focuses on observing natural, everyday interactions to capture subtle shifts in social communication and patterns of behaviour, and restricted and repetitive behaviours. In this review, we gathered and summarised all available studies up to March 2025 that used the BOSCC with autistic children, including both intervention studies and studies examining how well the BOSCC works. Across 19 studies including 789 children, we found that the BOSCC was consistently able to detect changes that occurred during a wide range of supports and programmes. The Social Communication subscale was particularly good at picking up changes, but the scale designed to measure repetitive behaviours was more inconsistent. The lack of changes in repetitive behaviours may reflect the diversity and important self-regulatory roles that repetitive behaviours can have, as well as the fact that many short-term interventions do not focus on changing them. The BOSCC was also found to be better at picking up changes in social communication compared to a diagnostic tool called the Autism Diagnostic Observation Schedule (ADOS). Overall, the evidence suggests that the BOSCC, particularly the Social Communication subscale, may be a useful way to detect changes in autistic communication over time. Future work should acknowledge that repetitive behaviours are not routinely targeted by supports intended to enhance communication and may serve a self-regulatory function, to manage sensory input, or to express emotions. This will help ensure that the BOSCC is used in a way that aligns with neurodiversity-affirming principles and supports ethically grounded research.

21 May 2025 in JMIR Preprints
Verified
Preprint
Open access
zartashia ghanizartashia ghani
zartashia ghani
Johan  JarlJohan Jarl
Johan Jarl
Peter AnderbergPeter Anderberg
Peter Anderberg
JBJohan Sanmartin Berglund
Johan Sanmartin Berglund
MAMaria Quintana Aparicio
Maria Quintana Aparicio
SSSanjib Saha
Sanjib Saha
BACKGROUND Support, Monitoring, and Reminder Technology for Mild Dementia (SMART4MD), a customized tablet app, was developed to improve or maintain the quality of life of people with mild cognitive impairment (MCI) and their informal caregivers. OBJECTIVE This study conducts an 18-month economic evaluation of the SMART4MD app, in addition to standard care, compared with standard care alone in Sweden and Spain, from a health care provider perspective. METHODS In a pragmatic randomized controlled trial, people with MCI and their informal caregivers were randomized to the intervention and control groups. Health care costs, quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios (ICERs) were measured in 345 Swedish people with MCI and their informal caregivers, and in 347 Spanish people with MCI. RESULTS The analysis showed higher incremental costs and lower QALYs for Swedish people with MCI than for controls, whereas higher incremental costs and higher QALYs were observed for Spanish people with MCI. The intervention was not found to be cost-effective for Swedish informal caregivers, with an ICER of €78,000/QALY (€1=US $1.16). CONCLUSIONS The differing findings regarding cost-effectiveness for people with MCI in Sweden and Spain highlight the need for further research with extended follow-up, ideally involving a larger sample size and conducted across different national contexts. CLINICALTRIAL ClinicalTrials.gov NCT03325699; https://clinicaltrials.gov/ct2/show/NCT03325699